Table 4 Vif/Vpr and Gag sequences containing G-to-A mutations that resulted in Stop/Start codon mutations, other mutations, or no mutations.
Sample | Total Sequences with Stop/Start Codon Mutations (%) | Total Sequences w/ Other Mutations (%) | Total Sequences w/ No Mutations (%) |
|---|---|---|---|
Vif/Vpr | Â | Â | Â |
DNA (Round 2 +3) | 83 (59.7%) | 30 (21.6%) | 26 (18.2%) |
Cellular Viral RNA (Round 2+3) | 24 (22.2%) | 22 (20.4%) | 62 (57.4%) |
Virion RNA (Round 2+3) | 13 (10.2%) | 16 (12.6%) | 98 (77.2%) |
Gag | Â | Â | Â |
DNA (Round 2) | 17 (70.8%) | 2 (8.3%) | 5 (20.8%) |
Cellular Viral RNA (Round 2) | 26 (22.4%) | 24 (20.7%) | 66 (56.9%) |
Virion RNA (Round 2) | 6 (6.3%) | 12 (12.5%) | 78 (81.3%) |